COVID-19 Symptoms and Mental Health Outcomes among Italian Healthcare Workers: A Latent Class Analysis.

COVID-19 Symptoms and Mental Health Outcomes among Italian Healthcare Workers: A Latent Class Analysis.

Publication date: Jul 15, 2024

The COVID-19 pandemic has led to long-lasting consequences for workers leading to what has been termed a “psychological pandemic”. Some categories, such as healthcare workers (HCWs), are considered high risk due to factors such as increased exposure and stressful working conditions. In this study, we investigate whether levels of posttraumatic stress symptoms and COVID-19-related fear (IES-6 and PSI-4) are associated with illness severity in a sample of 318 infected HCWs in Italy. To investigate the presence of different profiles of COVID-19 severity, Latent Class Analysis (LCA) was performed based on 11 symptoms. Differences in the IES-6 and PSI-4 scores across the latent classes were compared using the non-parametric Kruskal-Wallis (KW) test with Dunn’s multiple comparison post hoc testing. Our analyses show that the LCA identified three classes of symptoms, reflecting no/low, mild and severe symptoms. The classes include vomiting, confusion, conjunctivitis, diarrhea, dyspnea, headache, ageusia, fever, anosmia, osteo muscle articular pain and asthenia. We found that HCWs who experienced more intense symptoms reported significantly higher IES-6 and PSI-4 scores. Moreover, we found gender-related differences in IES-6 and PSI-4 scores as females exhibited higher levels than males. Indeed, these findings are useful for developing health prevention and emergency management programs.

Open Access PDF

Concepts Keywords
Asthenia COVID-19
Dyspnea healthcare workers
Healthcare LCA
Italian mental health
Males post-traumatic stress

Semantics

Type Source Name
disease MESH COVID-19
drug DRUGBANK Indoleacetic acid
disease MESH conjunctivitis
disease MESH emergency
disease MESH infection
disease IDO production
disease MESH arthralgia
disease MESH sore throat
disease MESH Asymptomatic infection
disease MESH Acute Respiratory Distress Syndrome
disease VO population
drug DRUGBANK Coenzyme M
disease MESH insomnia
disease MESH loneliness
disease MESH post traumatic stress disorder
disease IDO symptom
disease MESH influenza
disease MESH syndrome
disease MESH panic
disease MESH death
drug DRUGBANK Esomeprazole
disease MESH psychological distress
disease VO effective
disease MESH burnout
disease VO time
disease MESH return to work
disease VO frequency
disease VO age
drug DRUGBANK Tropicamide
drug DRUGBANK Gold
disease MESH uncertainty
drug DRUGBANK Hydrocortisone
disease VO report
disease IDO site
disease MESH lifestyle
disease MESH work related stress
drug DRUGBANK Trimebutine
disease IDO process
disease MESH Pneumonia
drug DRUGBANK Trestolone
disease MESH Comorbidity
disease MESH Phobia
disease VO organ
disease VO USA
disease VO company
disease MESH Psychiatric Disorder
disease MESH Adjustment Disorders
disease MESH Psychological Stress
drug DRUGBANK Guanosine
disease MESH Anxiety Disorders
disease MESH Violence
drug DRUGBANK Hyaluronic acid
drug DRUGBANK Pentaerythritol tetranitrate
disease VO protocol
disease MESH Secondary Traumatic Stress

Original Article

(Visited 2 times, 1 visits today)